Literature DB >> 25304719

Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T.

Georges Decker1, Petra Mürtz2, Jürgen Gieseke3, Frank Träber2, Wolfgang Block2, Alois M Sprinkart2, Christina Leitzen2, Timo Buchstab2, Christiana Lütter2, Heinrich Schüller2, Hans H Schild2, Winfried A Willinek2.   

Abstract

BACKGROUND AND
PURPOSE: Diffusion weighted imaging (DWI) as a functional MR technique allows for both qualitative and quantitative assessment of tumour cellularity and changes during therapy. The objective of this study was to evaluate changes of apparent diffusion coefficient (ADC) in biopsy proven prostate cancer (PCa) under intensity modulated radiotherapy (IMRT) at 3T. MATERIAL &
METHODS: Thirteen patients with biopsy proven PCa treated with intensity modulated external beam radiotherapy (IMRT) underwent four standardized MR examinations after approval of the local institutional review board. These included DWI at 3T on a strict time table: before, in between, directly after (between 1 and 4 days after the last radiation), as well as 3 months after IMRT. Quantitative analysis of two different ADCs, - the ADC(0,800) and the ADC(50,800), was performed dynamically over 4 time points in PCa, gluteal muscle and healthy prostate tissue.
RESULTS: In PCa, a significant increase of ADC(0,800)/ADC(50,800) values was measured under IMRT by about 16%/15% (P=0.00008/0.00017), 21%/21% (P=0.00006/0.00030), and 33%/34% (P=0.00004/0.00002) at the three time points compared to initial value. Healthy prostate tissue did not show any significant increase.
CONCLUSION: DWI is suitable as a biomarker for radiation therapy response of PCa by allowing the dynamic monitoring of treatment effectiveness.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  3T; DWI; IMRT; PCa

Mesh:

Year:  2014        PMID: 25304719     DOI: 10.1016/j.radonc.2014.07.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Evaluation of diffusion-weighted MRI and geometric distortion on a 0.35T MR-LINAC at multiple gantry angles.

Authors:  Benjamin Lewis; Anamaria Guta; Stacie Mackey; H Michael Gach; Sasa Mutic; Olga Green; Taeho Kim
Journal:  J Appl Clin Med Phys       Date:  2021-01-15       Impact factor: 2.102

Review 2.  The expanding landscape of diffusion-weighted MRI in prostate cancer.

Authors:  Andreas G Wibmer; Evis Sala; Hedvig Hricak; Hebert Alberto Vargas
Journal:  Abdom Radiol (NY)       Date:  2016-05

3.  The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC).

Authors:  Wei-Xiang Qi; Qing Zhang; Ping Li; Xiao-Meng Zhang; Guang-Yuan Zhang; Bin Wu; Jiade J Lu; Guo-Liang Jiang; Shen Fu
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-23       Impact factor: 4.553

4.  Diffusion weighted imaging for the differential diagnosis of benign vs. malignant ovarian neoplasms.

Authors:  Xiang-Fu Meng; Shi-Cai Zhu; Shao-Juan Sun; Ji-Cai Guo; Xue Wang
Journal:  Oncol Lett       Date:  2016-04-18       Impact factor: 2.967

5.  Changes in prostate apparent diffusion coefficient values during radiotherapy after neoadjuvant hormones.

Authors:  Andrew McPartlin; Lucy Kershaw; Alan McWilliam; Marcus Ben Taylor; Clare Hodgson; Marcel van Herk; Ananya Choudhury
Journal:  Ther Adv Urol       Date:  2018-10-11

Review 6.  Focal therapy for prostate cancer: the technical challenges.

Authors:  Annette Haworth; Scott Williams
Journal:  J Contemp Brachytherapy       Date:  2017-08-30

7.  Quantitative analysis of image quality for acceptance and commissioning of an MRI simulator with a semiautomatic method.

Authors:  Xinyuan Chen; Jianrong Dai
Journal:  J Appl Clin Med Phys       Date:  2018-03-24       Impact factor: 2.102

8.  Palliative radiotherapy to dominant symptomatic lesion in patients with hormone refractory prostate cancer (PRADO).

Authors:  Jesper Carl; Dirk Rades; Claudia Doemer; Cornelia Setter; Jürgen Dunst; Niels Henrik Holländer
Journal:  Radiat Oncol       Date:  2019-01-10       Impact factor: 3.481

9.  Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer.

Authors:  David Pasquier; Abderraouf Hadj Henni; Alexandre Escande; Emmanuelle Tresch; Nick Reynaert; Olivier Colot; Eric Lartigau; Nacim Betrouni
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

10.  Parameters Influencing PET Imaging Features: A Phantom Study with Irregular and Heterogeneous Synthetic Lesions.

Authors:  Francesca Gallivanone; Matteo Interlenghi; Daniela D'Ambrosio; Giuseppe Trifirò; Isabella Castiglioni
Journal:  Contrast Media Mol Imaging       Date:  2018-09-10       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.